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SUMMARY – There is an important relation between thyroid hormones and zinc. Esta-
blishment of low zinc levels in hypothyroidism and high levels in hyperthyroidism is a significant 
proof of this relation. The aim of the present study was to explore changes in serum levels of some 
elements and their relation to zinc in rats with hypothyroidism. Thirty adult male rats of Sprague-
Dawley type were divided into 3 equal groups: group 1, control; group 2, sham-hypothyroidism 
group supplemented with 10 mg/kg serum physiologic i.p. for 4 weeks; and group 3, hypothyroidism 
group supplemented with 10 mg/kg propylthiouracil i.p. for 4 weeks. Blood samples were collected 
from all animals by decapitation and serum calcium, phosphorus, chromium, copper, iron, magnesi-
um, selenium and zinc levels were analyzed using an atomic emission apparatus. Group 3 had lower 
calcium, selenium and zinc levels, and higher chromium, copper, iron and phosphorus levels (p<0.01 
all) relative to groups 1 and 2. Study parameters did not differ between groups 1 and 2. Results obta-
ined in this study indicate that hypothyroidism leads to changes in serum levels of some elements in 
rats. These changes may be associated with reduced zinc levels in hypothyroidism.
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Introduction
Zinc is a trace element, which is required for the 
activity of more than 300 enzymes1. It is also a struc-
tural component of several enzymes responsible for 
energy metabolism, including carbonic anhydrase, al-
kaline phosphatase, lactate dehydrogenase, carboxy-
peptidase, DNA-dependent RNA polymerase, and 
DNA polymerase1,2. Zinc, which plays an important 
role in the endocrine system due to its above-men-
tioned effects, is also necessary for optimal activity of 
many hormones, including thyroid hormones3. Low 
zinc concentrations have been reported in hypothy-
roidism and high zinc concentrations in hyperthyroid-
ism, both of which are diseases of the thyroid gland4. 
Zinc acts on the hypothalamus and hypophysis, and 
is necessary for the synthesis of thyrotropin-releasing 
hormone (TRH)5,6. It is also required for the activity 
of the enzyme 1,5’-deiodinase, which converts bio-
logically less active T4 (thyroxine) to its active form T3 
(triiodothyronine)7. Both trace elements and thyroid 
hormones play important roles in the human body. 
Due to all these effects, zinc can be said to be a mi-
cro food associated with thyroid hormones5. Results 
of previous studies demonstrate that changes occur in 
serum levels of various elements, zinc in particular, in 
case of impaired thyroid functioning8,9. Kucharzews-
ki et al.10 report that levels of zinc and selenium were 
significantly low in thyroid tissues of patients with 
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thyroid cancer. Iodine deficiency affects the thyroid 
function11,12. Similarly, in another study, zinc levels 
were lower in thyroid cancer patients than in normal 
subjects; while serum copper in the patients increased, 
the levels of iron, magnesium and manganese signifi-
cantly decreased postoperatively13. The levels of zinc, 
manganese and copper were shown to change mark-
edly in the erythrocyte and brain tissue of rats with 
induced iodine deficiency14. As reported by Dolev et 
al.15, not only plasma zinc levels, but also peripheral 
blood mononuclear cell zinc decreased in hypothyroid 
subjects. Previous studies indicate that the levels of 
some elements may change in relation to changes in 
thyroid activity. The present study aimed to explore 
changes in serum levels of some elements and their 
relation to zinc in rats with induced hypothyroidism.
Materials and Methods
This study was carried out at Experimental Medi-
cine Research and Application Center (SUDAM) of 
Selcuk University on the rats supplied thence. The 
study included 30 adult male rats of Sprague-Dawley 
type, weighing 190-230 g, which were allocated to 
groups as follows: group 1: control group without any 
intervention (n=10); group 2: sham- propylthiouracil 
(PTU) hypothyroidism group supplemented with 10 
mg/kg serum physiologic i.p. for 4 weeks (n=10); and 
group 3: PTU hypothyroidism group supplemented 
with 10 mg/kg PTU for 4 weeks (n=10)16.
Feeding of experimental animals 
Experimental animals were given 10 g feed per 100 
grams of body weight daily. They were kept in an en-
vironment with standard room temperature (21±1 oC) 
and 12 h dark/12 h light cycle. All injections were 
given between 09.00 and 10.00 a.m. At the end of 
the 4-week period, blood samples were collected from 
all animals by decapitation at 09.00-10.00 a.m. to be 
used in the analyses. The samples were stored at -80 
oC until analysis.
Sham-hypothyroidism
The experimental animals were supplemented 
with 0.1 NaOH/0.9% NaCl (1 mL/250 g) as placebo 
by intraperitoneal (i.p.) route, which dissolved PTU 
for 4 weeks.
Propylthiouracil supplementation
In order to induce hypothyroidism, 6-n-propyl-2-
thiouracil (PTU, Sigma Chemical Co., Dorset, UK) 
was dissolved in 0.1 NaOH/0.9% NaCl and adminis-
tered as 10 mg/kg/day (1 mL/250 g) by i.p. injection 
for 4 weeks.
Biochemical analyses
At the end of the experimental part of the study, 
serum samples were taken from all animals by decapi-
tation to determine calcium, phosphorus, chromium, 
iron, magnesium, selenium and zinc levels. Analyses 
of the study parameters were carried out using an in-
ductively coupled plasma emission spectrophotometry 
(ICP-AES, Varian Australia Pty Ltd., Australia) 
atomic emission apparatus at the Soil Department, 
Faculty of Agriculture, Selcuk University. The results 
were expressed as mg/L.
Statistical analysis
Statistical analysis was done using the SPSS sta-
tistical software. Results were expressed as mean ± 
standard deviation. Kruskal-Wallis variance analysis 
was used for between-group comparison and Mann 
Whitney U test was applied for the level of signifi-
cance at p<0.005.
Results and Discussion
Hypothyroidism group (group 3) had lower cal-
cium, selenium and zinc levels (p<0.01) (Table 1), and 
higher chromium, copper, iron and phosphorus levels 
(p<0.01) (Table 2) as compared with sham-hypothy-
roidism and control groups. There were no differences 
between control and sham-hypothyroidism groups for 
the mentioned elements (Tables 1 and 2).
In our study, the lowest zinc levels were obtained 
in the hypothyroidism group (group 3). One of the 
endocrine functions associated with zinc are chang-
es in thyroid hormone metabolism and energy con-
sumption of humans and animals who are on a low-
zinc diet4. Observing shrinkage in thyroid glands of 
guinea pigs with zinc defect, and parallel degenera-
tive changes, as well as atrophy in thyroid follicles, 
Gupta et al.17 report that zinc deficiency could directly 
influence thyroid hormone synthesis. Likewise, Har-
toma et al.18 argue that zinc could directly affect thy-
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Table 1. Serum calcium, selenium, zinc and magnesium levels in study groups (mg/L)
Group (n=10 each) Calcium Selenium Zinc Magnesium
1 Control 195.00±11.55a 2.71±0.25a 3.75±0.40a 46.50±9.57
2 Sham-hypothyroidism 194.00±10.60a 2.76±0.16a 3.60±0.30a 45.75±8.75
3 Hypothyroidism 168.00±09.50b 1.55±0.15b 2.25±0.23b 44.67±9.25
   p 0.01 0.01 0.01
Difference between the means with different superscripts in the same column is statistically significant (p<0.01) (a>b).
Table 2. Serum phosphorus, chromium, copper and iron levels in study groups (mg/L)
Group (n=10 each) Phosphorus Chromium Copper Iron
1 Control 270.80±20.22b 0.08±0.05b 2.91±0.55b 3.65±0.65b
2 Sham-hypothyroidism 274.76±22.50b 0.08±0.05b 3.01±0.75b 3.72±0.60b
3 Hypothyroidism 337.45±25.75a 0.14±0.05a 4.59±0.77a 4.75±0.65a
   p 0.01 0.01 0.01 0.01
Difference between the means with different superscripts in the same column is statistically significant (p<0.01) (a>b).
roid function and that it could play a role in thyroid 
hormone metabolism by increasing the production of 
thyroxin-binding proteins. Similar findings have been 
reported by Dhawan19. The effect of zinc on thyroid 
hormone levels was also shown by Wada and King7. 
However, it is clear that this relation is not unidirec-
tional. Thus, a decrease in thyroid hormones leads to 
the suppression of zinc levels4. In a study including 34 
hypothyroid patients, serum zinc content was shown 
to be remarkably decreased20. However, Alturfan et 
al.21 report that methimazole-induced hypothyroid-
ism reduced zinc levels. In the study by Kuriyama et 
al.22, red blood cell zinc concentration was significant-
ly lower in transient hypothyroidism patients than in 
permanent hypothyroidism patients. The low zinc 
levels we obtained in our study are in harmony with 
the results of the aforementioned researchers. Serum 
selenium levels in the hypothyroidism group (group 3) 
were lower than those in the other two groups. Simi-
lar findings have been reported by other researchers23. 
Selenium is a nutritive trace element required for reg-
ulation of thyroid hormones, redox state of vitamin 
C and functioning of other molecules, thanks to its 
protective effect against oxidative stress24. Selenium 
accumulates as selenocysteine in the active fragment 
of the wide domain of proteins. Until today, 15 sele-
noproteins have been purified or cloned, allowing the 
identification of their biological functions24. These are 
4 glutathione peroxidase enzymes representing the 
major class of selenoproteins that are functionally im-
portant24. Among the selenoproteins, iodothyronine 
deiodinases catalyze the conversion of inactive T3 to 
3’ diiodothyronine and pro-hormone thyroxin (T4) to 
active thyroid hormone 3,3’5 triiodothyronine25. As 
a result, selenium is very important in the modula-
tion of the regulatory role of thyroid hormones in the 
metabolism26. According to the report by Liu et al.14, 
the levels of selenium change markedly in various thy-
roid malfunctions. The levels of selenium in thyroid 
tissue of patients with thyroid cancer were shown to 
be significantly inhibited10. It has been reported that 
animals with selenium deficiency had lower thyroid 
hormone concentrations27, or that selenium values 
dropped in thyroid malfunctions28. Low selenium 
levels we obtained in the present study are consistent 
with the results of researchers who report altered sele-
nium levels in impaired thyroid functioning.
Reports indicate that calcium levels remain un-
changed or decrease in hypothyroidism29,30. However, 
hypocalcemia provoked by EDTA infusion to hypo-
thyroidism patients is deeper at long run31. The sensi-
tivity of bone and kidney to parathormone (PTH) de-
creases in hypothyroidism31. Therefore, the increased 
production of active vitamin D and PTH in hypo-
thyroidism does not cause hypercalcemia due to the 
decline in tissue sensitivity29-31. In our study, we also 
found significant decreases in serum calcium levels of 
the hypothyroidism group. In their study, O’Dell et 
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al.32 demonstrated that zinc deficiency in the body re-
sulted in insufficient calcium absorption. It has been 
reported that 1,25 dihydroxycholecalciferol levels in 
circulation dropped in zinc deficiency, or alternatively 
that zinc supplementation stimulated the synthesis 
of 1,25 dihydroxycholecalciferol33. Low calcium lev-
els we obtained in the hypothyroidism group seem to 
have resulted from the decrease in zinc levels.
In a study including thyroid cancer patients, pre-
operative magnesium values of the patients were not 
different from those in the controls, but declined sig-
nificantly after the operation13. Dolev et al.15 found a 
decline in urinary discharge and clearance of magne-
sium in hypothyroidism patients. Magnesium levels 
declined in the liver and brain tissues, remained un-
changed in the renal tissue, and increased in the heart 
tissue of rats with induced hypothyroidism34. How-
ever, Erdal et al.23 report that basal manganese levels 
are reduced in subclinical hypothyroidism. Results 
of studies on how magnesium values are affected in 
hypothyroidism seem contradictory, and are focused 
on changes in tissues. In our study, serum magnesium 
values did not differ among the groups. The result 
of our study regarding this parameter indicates that 
serum magnesium values do not change in hypothy-
roidism.
The hypothyroidism group (group 3) had higher 
chromium, copper, iron and phosphorus levels as 
compared with other groups in our study. It has been 
argued that copper metabolism is impaired in thyroid 
diseases35. Copper concentration in the renal tissue 
was shown to decrease in rats with induced hypothy-
roidism34. Similarly, it has been reported that copper 
levels increased in patients with thyroid cancer10, and 
that iodine deficiency significantly altered copper 
levels in the rat brain tissue14. But, Alturfan et al.21 
determined that copper levels were decreased in me-
thimazole-induced hypothyroidism. The high copper 
levels we obtained in our study uphold the findings of 
researchers who have argued that copper metabolism 
is impaired in thyroid malfunctions. Iron levels in rat 
tissues change in iodine deficiency14. Similar results 
were recorded on postoperative measurements in pa-
tients with thyroid cancer13. It has been reported that 
iron supplementation reduced hyperthyroidism in rats 
with induced hyperthyroidism and inhibited plasma 
ferritin levels36. However, Erdal et al.23 found that 
basal iron levels were decreased in subclinical hypo-
thyroidism. The high iron levels we found in our study 
indicate that this metal is influenced by impairments 
in thyroid metabolism. We could not determine anti-
oxidant molecules such as reduced glutathione (GSH) 
in the present study. However, we determined GSH 
levels in our previous study in experimental hypothy-
roidism37. Thus, it may be suggested that copper and 
zinc act as antioxidant molecules and exert their effects 
in an indirect manner in experimental hypothyroid-
ism. We could not find any result with which we could 
compare increased chromium and phosphorus levels 
we obtained in the hypothyroidism group (group 3). 
However, the findings we obtained demonstrate that 
these elements are at least affected by hypothyroid-
ism. The higher chromium, copper, iron and phos-
phorus levels we found in the hypothyroidism group 
may also be associated with low zinc levels recorded 
in the same group. McDonald and Keen38 noted the 
presence of an interaction between dietary zinc and 
other elements, and argued that excessive iron intake 
in particular might lead to zinc deficiency. The results 
of our study suggest an inverse correlation between 
iron and zinc. A balance was noted between zinc, an 
important trace element, and copper, iron and phos-
phorus31-33. It has been reported that high-dose zinc 
could impair copper-iron absorption41, and also that 
high-dose phosphorus-iron-copper might impair zinc 
absorption42,43. The high copper, iron and phosphorus 
values we obtained in this study could be considered 
to result from decreased zinc levels.
The results of this study indicate that hypothyroid-
ism brings about changes in the levels of some ele-
ments in rats. These changes may be associated with 
decreased zinc levels in hypothyroidism.
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Sažetak
ODNOS SERUMSKIH RAZINA KALCIJA, SELENA, MAGNEZIJA, FOSFORA, KROMA, BAKRA I 
ŽELJEZA PREMA CINKU KOD ŠTAKORA S IZAZVANIM HIPOTIROIDIZMOM
K. Baltaci, R. Mogulkoc  i M. Belviranli
Odnos između hormona štitnjače i cinka veoma je važan. Nalaz niskih razina cinka kod hipotiroidizma i visokih razi-
na kod hipertiroidizma značajan je dokaz ovoga odnosa. Cilj ovoga istraživanja bio je ispitati promjene serumskih razina 
nekih elemenata i njihov odnos prema cinku kod štakora s hipotiroidizmom. Trideset odraslih Sprague-Dawley štakora 
mužjaka podijeljeno je u tri jednake skupine: 1. kontrolna skupina; 2. skupina s lažnim hipotiroidizmom, s dodatkom 10 
mg/kg fiziološkog seruma i.p. kroz 4 tjedna; 3. skupina s hipotiroidizmom, s dodatkom 10 mg/kg propiltiouracila i.p. kroz 
4 tjedna. Uzorci krvi prikupljeni su dekapitacijom, a serumske razine kalcija, fosfora, kroma, bakra, željeza, magnezija, 
selena i cinka analizirane su primjenom uređaja za atomsku emisiju. Skupina 3. imala je niže razine kalcija, selena i cinka 
te više razine kroma, bakra, željeza i fosfora (p<0,01 sve) u odnosu na skupine 1. i 2. Ovi parametri nisu se razlikovali među 
skupinama 1. i 2. Rezultati dobiveni u ovom ispitivanju ukazuju na to da hipotiroidizam dovodi do promjena u razinama 
nekih elemenata kod štakora. Ove promjene mogle bi biti udružene sa sniženim razinama cinka u hipotiroidizmu.  
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